Skip to main content Deutsch

Webseiten-Inhalte

New methods take us closer to targeted, personalised cancer treatment ... Hall of MedUni Vienna from 28 - 30 September. This specialist symposium brings together top international researchers from many disciplines and representatives from industry. Thomas Beyer, Gerda Egger, Marcus Hacker, Lukas Kenner, Oliver Langer, Markus Mitterhauser, Shahrokh Shariat, Wolfgang Wadsak... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2016/news-september-2016/new-methods-take-us-closer-to-targeted-personalised-cancer-treatment/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=1&cHash=3e7be1f00fe516b96e7f2d0578a17f16
New methods take us closer to targeted, personalised cancer treatment ... Hall of MedUni Vienna from 28 - 30 September. This specialist symposium brings together top international researchers from many disciplines and representatives from industry. Thomas Beyer, Gerda Egger, Marcus Hacker, Lukas Kenner, Oliver Langer, Markus Mitterhauser, Shahrokh Shariat, Wolfgang Wadsak... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2016/news-september-2016/new-methods-take-us-closer-to-targeted-personalised-cancer-treatment/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=2&cHash=5e06c322e3acd54ce78f775fc7d25c60
PSMA ligand PET/MRI provides accurate diagnosis of prostate cancer ... Mitterhauser, Theresa Balber, Neydher Berroteran-Infante, Marko Grahovac, John Babich, Christian Seitz, Gero Kramer, Martin Susani, Peter Mazal, Lukas Kenner, Shahrokh F. Shariat, Marcus Hacker, Markus Hartenbach: PSMA ligand PET/MRI for primary prostate cancer: Staging performance and clinical impact. Clin... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2018/news-im-september-2018/psma-ligand-petmri-provides-accurate-diagnosis-of-prostate-cancer/?cHash=b0549f0a33c9ec45e0bff024ce7f93a8&tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=4
New methods take us closer to targeted, personalised cancer treatment ... Hall of MedUni Vienna from 28 - 30 September. This specialist symposium brings together top international researchers from many disciplines and representatives from industry. Thomas Beyer, Gerda Egger, Marcus Hacker, Lukas Kenner, Oliver Langer, Markus Mitterhauser, Shahrokh Shariat, Wolfgang Wadsak... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2016/news-september-2016/new-methods-take-us-closer-to-targeted-personalised-cancer-treatment/?L=3
New methods take us closer to targeted, personalised cancer treatment ... Hall of MedUni Vienna from 28 - 30 September. This specialist symposium brings together top international researchers from many disciplines and representatives from industry. Thomas Beyer, Gerda Egger, Marcus Hacker, Lukas Kenner, Oliver Langer, Markus Mitterhauser, Shahrokh Shariat, Wolfgang Wadsak... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2016/news-september-2016/new-methods-take-us-closer-to-targeted-personalised-cancer-treatment/university/?L=3
New methods take us closer to targeted, personalised cancer treatment ... Hall of MedUni Vienna from 28 - 30 September. This specialist symposium brings together top international researchers from many disciplines and representatives from industry. Thomas Beyer, Gerda Egger, Marcus Hacker, Lukas Kenner, Oliver Langer, Markus Mitterhauser, Shahrokh Shariat, Wolfgang Wadsak... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2016/news-september-2016/new-methods-take-us-closer-to-targeted-personalised-cancer-treatment/medicine-science/?L=3
PSMA ligand PET/MRI provides accurate diagnosis of prostate cancer ... Mitterhauser, Theresa Balber, Neydher Berroteran-Infante, Marko Grahovac, John Babich, Christian Seitz, Gero Kramer, Martin Susani, Peter Mazal, Lukas Kenner, Shahrokh F. Shariat, Marcus Hacker, Markus Hartenbach: PSMA ligand PET/MRI for primary prostate cancer: Staging performance and clinical impact. Clin... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2018/news-im-september-2018/psma-ligand-petmri-provides-accurate-diagnosis-of-prostate-cancer/?L=3
PSMA ligand PET/MRI provides accurate diagnosis of prostate cancer ... Mitterhauser, Theresa Balber, Neydher Berroteran-Infante, Marko Grahovac, John Babich, Christian Seitz, Gero Kramer, Martin Susani, Peter Mazal, Lukas Kenner, Shahrokh F. Shariat, Marcus Hacker, Markus Hartenbach: PSMA ligand PET/MRI for primary prostate cancer: Staging performance and clinical impact. Clin... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2018/news-im-september-2018/psma-ligand-petmri-provides-accurate-diagnosis-of-prostate-cancer/medicine-science/?L=3
PSMA ligand PET/MRI provides accurate diagnosis of prostate cancer ... Mitterhauser, Theresa Balber, Neydher Berroteran-Infante, Marko Grahovac, John Babich, Christian Seitz, Gero Kramer, Martin Susani, Peter Mazal, Lukas Kenner, Shahrokh F. Shariat, Marcus Hacker, Markus Hartenbach: PSMA ligand PET/MRI for primary prostate cancer: Staging performance and clinical impact. Clin... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2018/news-im-september-2018/psma-ligand-petmri-provides-accurate-diagnosis-of-prostate-cancer/people-of-the-meduni-vienna/?L=3
Bürgermeisterfonds der Stadt Wien fördert zahlreiche Forschungsprojekte der MedUni Wien ... Kastrationsresistenten Krebs der ProstataProjekt-Leiter: Lukas KennerKlinisches Institut für Pathologie Janus kinase directed mesenchymal tissue response to inflammation in arthritisProjekt-Leiter: Hans-Peter KienerUniversitätsklinik für Innere Medizin III, Klinische Abteilung für Rheumatologie Computergestützte... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2017/news-im-maerz-2017/buergermeisterfonds-der-stadt-wien-foerdert-zahlreiche-forschungsprojekte-der-meduni-wien/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=2&cHash=0e97ab1a5adc9609e0129862c5561383